Gene-Disorder Association · Article
Gene
FLT3 Fms Related Receptor Tyrosine Kinase 3
×
First reported
2002
Supporting publications
5
Manually curated Approved treatment annotated
Association Review
In brief The association between FLT3 (Fms Related Receptor Tyrosine Kinase 3) and Myeloproliferative Neoplasm is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
2
Compounds
1
Trials
7 of 516 via FLT3 compounds
Publications
5
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources 1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
3 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Myeloproliferative Neoplasm
The disorder 10 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Interventions
Therapeutics 1 compound or drug
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
06
Human studies
Clinical trials 516 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
5 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
08
Provenance
References & sources 12 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access